Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2005
03/09/2005EP1512429A1 Needles coated with vaccine
03/09/2005EP1512414A1 Hapten-carrier conjugates for treating and preventing nicotine addiction
03/09/2005EP1512412A1 Method to identify anti-apoptotic compounds
03/09/2005EP1512110A2 Screening process
03/09/2005EP1512014A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
03/09/2005EP1511846A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
03/09/2005EP1511845A2 Immunostimulatory oligonucleotides and uses thereof
03/09/2005EP1511772A2 Method for obtaining anti-idiotype antibodies
03/09/2005EP1511768A1 Immunogenic compositions
03/09/2005EP1511766A2 Immunogenic composition and peptide sequences for prevention and treatment of an hsv condition
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511514A1 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
03/09/2005EP1511513A2 Immunogenic compositions comprising a xenogenic prostate protein p501s
03/09/2005EP1511512A1 Novel uses of parapoxvirus preparations
03/09/2005EP1511511A2 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
03/09/2005EP1511509A1 Compositions and methods for treating diabetes
03/09/2005EP1511506A1 Compositions and methods for preventing, treating and diagnosing diabetes
03/09/2005EP1511505A2 Novel therapies and methods of screening for therapeutic compounds
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511377A1 Sterilization, stabilization and preservation of functional biologics
03/09/2005EP1392354B1 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic wounds
03/09/2005EP1237916B1 Ing2, an iaps associated cell cycle protein, compositions and methods of use
03/09/2005EP1233783B1 Hbv/hcv virus-like particle
03/09/2005EP0932613B1 Blocking expression of virulence factors in s. aureus
03/09/2005EP0876612B1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules
03/09/2005EP0842273B1 Receptor ligand vegf-c
03/09/2005EP0801679B1 Monoclonal antibodies which promote central nervous system remyelination
03/09/2005EP0756005B1 Gene coding for adseverin
03/09/2005CN1592751A Nucleic acids encoding a recombinant 250 kDa antigen from sporozoites/merozoites of eimeria maxima and their uses
03/09/2005CN1592720A Metal binding proteins and associated methods
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592636A Immunotherapeutic combinations for the treatment of tumors
03/09/2005CN1592635A Autologous growth factor cocktail composition, method of production and use
03/09/2005CN1592633A T-cell epitodes in carboxypeptidase G2
03/09/2005CN1590552A Recombination VSV virus carrier and recombination VSV virus and its preparation method and use
03/09/2005CN1590542A Aids recombination gland virus vaccine
03/09/2005CN1590404A Antigenic meningococcal peptides
03/09/2005CN1589903A Methods for amyloid removal using anti-amyloid antibodies
03/09/2005CN1589902A Application of anti-lymphotoxin-beta receptor antibodies in preparation of medical composition
03/09/2005CN1589901A Foot and mouth disease bivalent polypeptide vaccine and its preparation method and use
03/09/2005CN1192236C In vitro method for determining presence of protein in separated biological sample
03/09/2005CN1192101C Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria
03/09/2005CN1192038C Monoclonal antibodies against HIV-1 and vaccines made thereof
03/09/2005CN1191872C Device for delivery of macromolecules into cells
03/09/2005CN1191861C Medicinal compositions containing anti-Fas antibody
03/09/2005CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit
03/09/2005CN1191859C Docetaxel in combination with rhumab HER2 monoclone antibody for treatment of cancers
03/09/2005CN1191858C Method for inhibiting brain tnmor growth
03/09/2005CN1191857C potentiation of anti-CD38-immunotoxin cytotoxicity
03/09/2005CN1191856C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
03/09/2005CN1191855C Remedies for lymphocytic tumors
03/09/2005CN1191854C Model membrane systems
03/09/2005CN1191853C Preparations containing virus-like particles as immunopotentiators administered through mucosa
03/09/2005CN1191852C Vaccine
03/09/2005CN1191851C Polypeptide comprising amino acid of AN N-terminal choline binding protein truncate, vaccine derived therefrom and uses thereof
03/09/2005CN1191850C Treatment of hemoatological malignancies associated with circulating tumor cells using chimeric anti -CD20 antibody
03/09/2005CN1191823C Cell for producing alginate capsules
03/08/2005US6864365 Bacterial fimbrial system for presentation of heterologous peptide sequences
03/08/2005US6864363 Dipeptidylpeptidases and methods of use
03/08/2005US6864227 Artery-and vein-specific proteins and uses therefor
03/08/2005US6864070 Polypeptide for use in the treatment of vision defects and psychological disorders
03/08/2005US6863896 Plant lectins as mucosal adjuvants
03/08/2005US6863894 Mutant Salmonella; anticancer agents
03/08/2005US6863893 Vaccination of mammals with pneumococcal derived polypeptides that include an alpha helix but exclude a choline binding region as a mechanism for stimulating production of an antibody that protects vaccine recipient from infection
03/08/2005US6863892 Diagnosi and treatment of cancer; obtain tissue sample, monitor gene expression in sample, monitor methylation in sample, compare to control, evaluate for cancer
03/08/2005US6863890 Treatment of AIDS with antibodies to gamma interferon, alpha interferon and TNF-alpha
03/08/2005CA1341474C Purified igm
03/06/2005WO2005051991A2 Mucin antigen vaccine
03/06/2005CA2544946A1 Mucin antigen vaccine
03/03/2005WO2005019464A1 Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer
03/03/2005WO2005019455A1 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
03/03/2005WO2005019435A2 Anti-cancer vaccines
03/03/2005WO2005019434A2 Serine protease inhibitors for treatment of bacterial infections
03/03/2005WO2005019432A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis
03/03/2005WO2005019431A2 Selective inhibition of toll-like receptor-2
03/03/2005WO2005019412A2 Mucosal immunization to prevent prion infection
03/03/2005WO2005019411A2 Ancestral viruses and vaccines
03/03/2005WO2005019409A2 Combinatorial protein library screening by periplasmic expression
03/03/2005WO2005019270A2 Endotheliase-2 ligands
03/03/2005WO2005019266A2 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
03/03/2005WO2005019249A2 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
03/03/2005WO2005019248A1 Hiv immunogenic complexes
03/03/2005WO2005019246A1 Coronavirus vaccines, therapeutics and diagnostics
03/03/2005WO2005018668A1 Method of inducing immune tolerance
03/03/2005WO2005018665A1 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium spp
03/03/2005WO2005018610A1 In vivo targeting of dendritic cells
03/03/2005WO2005018580A2 Anti-cancer virus desensitization method
03/03/2005WO2005018575A2 Estrogen receptor modulators and uses thereof
03/03/2005WO2005018574A2 Immunostimulatory combinations and treatments
03/03/2005WO2005018544A2 Therapy-enhancing glucan
03/03/2005WO2005018539A2 Influenza hemagglutinin and neuraminidase variants
03/03/2005WO2005018536A2 Agonist antibodies that specifically bind the glucagon like peptide-1 receptor
03/03/2005WO2005005465A3 Methods and compositions to enhance immune responses via recall antigens
03/03/2005WO2005003330A3 Acapsular p. multocida hyae deletion mutants
03/03/2005WO2004110481A3 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
03/03/2005WO2004080400A3 Adjuvanted bovine vaccines
03/03/2005WO2004075835A3 Methods for the treatment of renal cell carcinoma
03/03/2005WO2004071411A3 Methods and compositions in treating pain and painful disorders using 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620
03/03/2005WO2004069182A3 Active immunization to generate antibodies to soluble a-beta
03/03/2005WO2004060915A3 Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
1 ... 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 ... 1823